Collagen needs a clearer explanation
Collagen is the body’s most abundant structural protein. It is found in skin, tendons, ligaments, bone and cartilage, so it is easy to understand why it attracts attention in products for active, working and older dogs.
Unfortunately, the simplest marketing story is wrong. Collagen does not pass from the dog’s bowl directly into a worn joint and patch it like filler. Like other dietary proteins, it is digested into amino acids and small peptides before absorption. Those nutrients then enter the body’s normal pool of building materials and biological signals.
That does not make collagen pointless. It means its role should be described accurately.
What are hydrolysed collagen peptides?
Hydrolysis breaks larger collagen proteins into smaller peptides. This makes them dispersible and digestible, and gives the ingredient a different profile from ordinary food protein.
FieldStrength Naturals Joint+ uses hydrolysed bovine collagen peptides associated with collagen Types I and III. Type I is abundant in tissues such as tendon, ligament, bone and skin; Type III commonly occurs alongside it in connective tissues.
This is different from undenatured type II collagen, often abbreviated UC-II, which is used in some joint products at much smaller amounts and is proposed to act through a different biological route. Evidence for UC-II should not be borrowed to advertise hydrolysed Types I and III. They are distinct ingredients, forms and formulation strategies.
What can peptides contribute?
After digestion, collagen peptides provide amino acids rich in glycine and proline-related components used throughout normal protein turnover. Researchers have also detected certain food-derived peptides in circulation and investigated whether they influence connective-tissue cells.
The responsible claim is that hydrolysed collagen peptides provide specific protein building blocks and can support normal connective-tissue maintenance as part of the diet. Saying that they rebuild cartilage, repair tendons or reverse joint disease would go much further than the evidence allows—and would turn nutritional language into a medicinal claim.
The dog’s complete diet still supplies the majority of its protein and energy. A collagen complementary feed is not a replacement for balanced nutrition.
What does recent canine research suggest?
Direct canine research is developing. A 2024 randomised, double-blind, placebo-controlled study investigated bioactive collagen peptides in client-owned dogs with naturally occurring osteoarthritis. The researchers reported improvements in some owner- and veterinary-assessed measures compared with placebo.
That is useful evidence because it studies dogs rather than simply extrapolating from humans. It is still one study of a particular commercial peptide preparation, population, dose and duration. Replication and comparison with other formulations are important before drawing broad conclusions.
Other canine studies have assessed collagen within multi-ingredient supplements. These can support the plausibility of a complete formulation but cannot isolate the collagen contribution. Reviews of canine joint nutraceuticals similarly note variation in study quality, product type and outcome measures.
So the evidence is promising, not absolute. “Clinically investigated” is more defensible than “clinically proven to rebuild joints.”
Why combine collagen with other ingredients?
Connective-tissue support is not a one-ingredient problem. Joint+ pairs collagen peptides with green-lipped mussel, salmon oil, rosehip, Boswellia, turmeric, black pepper, coconut oil and linseed oil. Each has a different nutritional role: structural protein components, marine and plant lipids, and botanical compounds.
The blend is designed around complementary contributions, not the idea that adding many fashionable ingredients guarantees a result. The finished product, feeding amount, ingredient quality and the dog’s wider routine all matter.
This is also why Joint+ is not simply described as a stronger Original. Original provides broad everyday support for normal mobility, recovery, coat and condition. Joint+ has a more focused joint and connective-tissue emphasis, led by its collagen peptide component.
Which dogs might owners consider it for?
Owners often consider focused connective-tissue support for dogs doing regular work or sport, mature dogs whose movement is changing gradually, and dogs with demanding daily routines. It may also appeal to owners who want collagen peptides within an easy-to-feed paste rather than a separate powder.
None of those situations replaces veterinary assessment. Lameness, swelling, pain, injury, rapid deterioration or reluctance to bear weight are not normal supplement-selection questions. They are reasons to speak to a vet.
For routine use, follow the feeding instructions and give the product time to become part of a stable routine. Record ordinary movements weekly. Body condition is crucial: excess weight increases the mechanical load on joints, and addressing it can be more meaningful than adding another supplement.
Quality questions worth asking
Look for the animal source, whether the collagen is hydrolysed, and which collagen form the evidence concerns. Avoid products that blur hydrolysed Types I and III with undenatured Type II.
Also look for realistic language. Collagen belongs in a nutritional conversation about normal tissue maintenance and mobility support. Claims about regenerating cartilage or replacing veterinary treatment should be treated cautiously.
The practical takeaway
Hydrolysed collagen peptides offer a targeted protein profile rather than a physical cartilage patch. Recent dog-specific research makes them a credible and developing ingredient for focused complementary feeds, provided that the exact form is identified and claims remain proportionate.
In Joint+, bovine collagen peptides sit at the centre of a broader joint and connective-tissue formula. They are one useful part of good management alongside complete nutrition, appropriate exercise, healthy body condition and veterinary care when needed.
Read more on our Ingredients page, view Joint+ in the shop, or visit the FAQs.
Sources and further reading
- 2024 canine randomised trial, https://pubmed.ncbi.nlm.nih.gov/39298537/ and https://pmc.ncbi.nlm.nih.gov/articles/PMC11412516/
- canine collagen review, https://pmc.ncbi.nlm.nih.gov/articles/PMC11919810/
- multi-ingredient collagen study, https://pmc.ncbi.nlm.nih.gov/articles/PMC8541357/
—